Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 211 Results March 12, 2020 MINERVA NEUROSCIENCES UPDATES MARKET ON SHARE PRICE DROP AND TRADING HALT March 9, 2020 Minerva Neurosciences Reports Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates March 2, 2020 Minerva Neurosciences to Report Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates on March 9, 2020 February 28, 2020 Minerva Neurosciences to Host Key Opinion Leader Meeting on Avolition, the Most Central Domain for the Successful Treatment of Negative Symptoms in Schizophrenia February 5, 2020 Minerva Neurosciences Announces Completion of Patient Enrollment in Phase 3 Trial of Roluperidone for the Treatment of Negative Symptoms in Schizophrenia January 6, 2020 Minerva Neurosciences Announces Completion of Patient Screening in Phase 3 Trial of Roluperidone for the Treatment of Negative Symptoms in Schizophrenia December 18, 2019 Minerva Neurosciences Reports Topline Results From Phase 2b Trial of MIN-117 in Major Depressive Disorder November 14, 2019 Minerva Neurosciences to Present at Jefferies London Healthcare Conference on November 21, 2019 November 4, 2019 Minerva Neurosciences Reports Third Quarter 2019 Financial Results and Business Updates October 28, 2019 Minerva Neurosciences to Report Third Quarter 2019 Financial Results and Business Updates on November 4, 2019 «...678910...20...»